Research and Development
Modern Pharmaceutical Technologies
Our research and development activities and plans for the future include the following:
Production of Biologics and Vaccines for Specialized Medical Fields
Developing technology for the production of various vaccines and biological drugs to treat metabolic diseases, rheumatology, cancer, MS, cardiovascular diseases, obstetrics and gynecology, and hematology.
Optimizing Drug Formulation and Increasing Efficacy
Developing novel drug delivery forms to improve quality, bioavailability, safety, and efficacy in treating various diseases while facilitating ease of use for patients.
Biosimilars
Biosun Pharmed has placed the production process of three types of proteins, filling, final dose determination, and quality control of intermediates, APIs, and final drug doses on its agenda. Research and development equipment is essential to our growth. In this regard, the Biosimilar project has not only produced high-quality products but also aims to achieve the highest standards of safety for both products and employees. To this end, the Biosun Pharmed factory, with over 8,000 square meters of floor space across five floors, features 2,700 square meters of cleanroom facilities.
Peptides
As a leading company in the production and supply of advanced medications, Biosun Pharmed strives to step toward exporting products to global markets using the latest modern knowledge. In line with this, the peptide drug project was designed based on the production of three forms: powder vials, liquid vials, and Pre-Filled Syringes (PFS). Launching this production unit will bring more than 3 million doses of medication to the market annually in accordance with the latest cGMP, EMEA, and WHO standards and guidelines. In addition to being competitive with world-class products, this will result in significant foreign currency savings. This project, spanning three floors with an approximate area of 3,500 square meters, consists of various sections:
Changing rooms, weighing, formulation, quality control, vial manufacturing, washing lines, sterilization and vial filling, Pre-Filled Syringe (PFS) manufacturing and filling, warehouses, cold storage, visual inspection, blistering, packaging, purified water systems, utilities, and support.
With the goal of maintaining product quality while ensuring employee safety, Biosun Pharmed has included the use of production lines equipped with isolators and environmental controls for high-risk (cytotoxic) products in its plans. These isolators will be built and utilized based on modern pharmaceutical standards and the latest technology.
Vaccines
The technical knowledge for the production and quality control of the Pentavalent vaccine has been localized at Biosun Pharmed. At the Biosun Pharmed production line in Barekat City, the vaccine will also be filled into vials. Consequently, the production capacity of this vaccine will increase to the extent that Biosun Pharmed will not only supply the approximately 6 million annual doses of the Pentavalent vaccine required by the country but will also be capable of producing several times this amount for export.
